請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/66466
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 梁碧惠 | |
dc.contributor.author | Yi-Bing Zeng | en |
dc.contributor.author | 曾依冰 | zh_TW |
dc.date.accessioned | 2021-06-17T00:37:13Z | - |
dc.date.available | 2012-03-02 | |
dc.date.copyright | 2012-03-02 | |
dc.date.issued | 2011 | |
dc.date.submitted | 2012-02-01 | |
dc.identifier.citation | 1. Riguera, R. Isolating bioactive compounds from marine organisms. J. Mar. Biotechnol. 1997, 5, 187-193.
2. Vincken, J.-P.; Heng, L.; de Groot, A.; Gruppen, H. Saponins, classification and occurence in the plant kingdom. Phytochemistry 2007, 68, 275-297. 3. Yu, B.; Sun, J. Current synthesis of triterpene saponins. Chem.-Asian J. 2009, 4, 642-654. 4. Park, J. D.; Rhee, D. K.; Lee, Y. H. Biological activities and chemistry of saponins from Panax ginseng C. A. Meyer. Phytochem. Rev. 2005, 4, 159-175. 5. Lanzotti, V. Bioactive saponins from Allium and Aster plants. Phytochem. Rev. 2005, 4, 95-110. 6. Kalinowska, M.; Zimowski, J.; Paczkowski, C.; Wojciechowski, Z. A. The formation of sugar chains in triterpenoid saponins and glycoalkaloids. Phytochem. Rev. 2005, 4, 237-257. 7. Kalinin, V. I.; Silchenko, A. S.; Avilov, S. A.; Stonik, V. A.; Smirnov, A. V. Sea cucumbers triterpene glycosides, the recent progress in structural elucidation and chemotaxonomy. Phytochem. Rev. 2005, 4, 221-236. 8. Francis, G.; Keem, Z.; Makkar, H. P. S.; Becker, K. The biological action of saponins in animal systems: a review. Br. J. Nutr. 2002, 88, 587-605. 9. Choi S.; Jung S.-Y.; Kim C.-H.; Kim H.-S.; Rhim H.; Kim S.-C.; Nah S.-Y., Effect of ginsenosides on voltage-dependent Ca2+ channel subtypes in bovine chromaffin cells. J. Ethnopharmacol. 2001, 74, 75-81. 10. Kashiwada, Y.; Wang, H. K.; Nagao, T.; Kitanaka, S.; Yasuda, I.; Fujioka, T.; Yamagishi, T.; Cosentino, L. M.; Kozuka, M.; Okabe, H.; Ikeshiro, Y.; Hu, C. Q.; Yeh, E.; Lee, K. H. Anti-AIDS agents 38. anti-HIV activity of 3-O-acyl ursolic acid derivative. J. Nat. Prod. 1998, 61, 1090-1095. 11. Liu, J. Pharmacology of oleanolic acid and ursolic acid. J. Ethnopharmacol. 1995, 49, 57-68. 12. Zhang, Y.; Li, J. X.; Zhao, J. W.; Wang, S. Z.; Pan, Y.; Tanaka, K.; Kadota, S. Synthesis and activity of oleanolic acid derivatives, a novel class of inhibitors of osteoclast formation. Bioorg. Med. Chem. Lett. 2005, 15, 1629-1632. 13. Chen, J.; Liu, J.; Zhang, L. Y.; Wu, G. Z.; Hua, W. Y.; Wu, X. M.; Sun, H. B. Pentacyclic triterpenes. part 3: synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase. Bioorg. Med. Chem. Lett. 2006, 16, 2915-2919. 14. Singh, G. B.; Singh, S.; Bani, S.; Gupta, B. D.; Banerjee, S. K. Anti-inflammatory activity of oleanolic acid in rats and mice. J. Pharm. Pharmacol. 1992, 44, 456-458. 15. Rao, A. V.; Sung, M. K. Saponins as anticarcinogens. J. Nutr. 1995, 125, 717S-724S. 16. Allouche, Y.; Warleta, F.; Campos, M. ; Sanchez-Quesada, C.; Uceda, M.; Beltran, G.; Gaforio, J. J. Antioxidant, antiproliferative, and pro-apoptotic capacities of pentacyclic triterpenes found in the skin of olives on MCF-7 human breast cancer cells and their effects on DNA damage. J. Agric. Food Chem. 2011, 59, 121-130. 17. Park, H. J.; Kwon, S. H.; Lee, J. H.; Lee, K. H.; Miyamoto, K.; Lee, K. T. Kalopanaxsaponin A is a basic saponin structure for the antitumor activity of hederagenin monodesmosides. Planta Med. 2001, 67, 118-121. 18. Zhang, Y. N.; Zhang, W.; Hong, D.; Shi, L.; Shen, Q.; Li, J. Y.; Li, J.; Hu, L. H. Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities. Bioorg. Med. Chem. 2008, 16, 8697-8705. 19. Li, J. F.; Chen, S. J.; Zhao, Y.; Li, J. X. Glycoside modification of oleanolic acid derivatives as a novel class of anti-osteoclast formation agents. Carbohydr. Res. 2009, 344, 599-605. 20. Zhu, Y. M.; Shen, J. K.; Wang, H. K.; Cosentino, L. M.; Lee, K. H. Synthesis and anti-HIV activity of oleanolic acid derivatives. Bioorg. Med. Chem. Lett. 2001, 11, 3115-3118. 21. Wang, X. Y.; Chen, X. L.; Tang, H. F.; Gao, H.; Tian, X. R.; Zhang, P. H. Cytotoxic triterpenoid saponins from the rhizomes of Anemone taipaiensis. Planta Med. 2011, 77, 1550-1554. 22. Yoshikawa, M.; Morikawa, T.; Yamamoto, K.; Kato, Y.; Nagatomo, A.; Matsuda, H. Floratheasaponins A-C, acylated oleanane-type triterpene oligoglycosides with anti-hyperlipidemic activities from flowers of the tea plant (Camellia sinensis). J. Nat. Prod. 2005, 68, 1360-1365. 23. Voutquenne, L.; Guinot, P.; Thoison, O.; Sevenet, T.; Lavaud, C. Oleanolic glycosides from Pometia ridleyi. Phytochemistry 2003, 64, 781-789. 24. Fujioka, T.; Kashiwada, Y.; Okabe, H.; Mihashi, K.; Lee, K. H. Antitumor agents 171. cytotoxicities of lobatosides B, C, D, and E, cyclic bisdesmosides isolated from Actinostemma lobatum maxim. Bioorg. Med. Chem. Lett. 1996, 6, 2807-2810. 25. Park, S. H.; Oh, S. R.; Jung, K. Y.; Lee, I. S.; Ahn, K. S.; Kim, J. K.; Lee, J. J.; Lee H. K. Anticomplement activities of oleanolic acid monodesmosides and bisdesmosides isolated from Tiarella polyphylla. Arch. Pharm. Res. 1999, 22, 428-431. 26. Lee, K. T.; Sohn, I. C.; Park, H. J.; Kim, D. W.; Jung, G. O.; Park, K. Y. Essential moiety of antimutagenic and cytotoxic activity of heeder agenin monodesmosides and bidesmosides isolated from the stem bark of Kalopanox pictus. Planta Med. 2000, 66, 329-332. 27. Chaturvedula, V. S. P.; Schilling, J. K.; Miller, J. S.; Andriantsiferana, R.; Rasamison, V. E.; Kingston, D. G. I. New cytotoxic oleanane saponins from the infructescences of Polyscias amplifolia from the Madagascar rainforest. Planta Med. 2003, 69, 440-444. 28. Abdel-Kader, M.; Hoch, J.; Berger, J. M.; Evans, R.; Miller, J. S.; Wisse, J. H.; Mamber, S. W.; Dalton, J. M.; Kingston, D. G. I. Two bioactive saponins from Albizia subdimidiata from the Suriname rainforest. J. Nat. Prod. 2001, 64, 536-539. 29. Seo, Y.; Hoch, J.; Abdel-Kader, M.; Malone, S.; Derveld, I.; Adams, H.; Werkhoven, M. C. M.; Hisse, J. H.; Mamber, S. W.; Dalton, J. M.; Kingston, D. G. I. Bioactive saponins from Acacia tenuifolia from the Suriname rainforest. J. Nat. Prod. 2002, 65, 170-174. 30. Hamed, A. I.; Piacente, S.; Autore, G.; Marzocco, S. ;Pizza, C.; Oleszek, W. Antiproliferative hopane and oleanane glycosides from the roots of Glinus lotoides. Planta Med. 2005, 71, 554-560. 31. Melek, F. R.; Miyase, T.; Ghaly, N. S.; Nabil, M. Triterpenoid saponins with N-acetyl sugar from the bark of Albizia procera. Phytochemistry 2007, 68, 1261-1266. 32. Khan, I. A.; Clark, A. M.; Mcchesney, J. D. Antifungal activity of a new triterpenoid glycoside from Pithecellobium racemosum (M.). Pharm. Res. 1997, 14, 358-361. 33. Zhang, H.; Samadi, A. K.; Rao, K. V.; Cohen, M. S.; Timmwemann, B. N. Cytotoxic oleanane-type saponins from Albizia inundata. J. Nat. Prod. 2011, 74, 477-482. 34. Ikeda, T.; Fujiwara, S.; Araki, K.; Kinjo, J.; Nohara, T.; Miyoshi, T. Cytotoxic glycosides from Albizia julibrissin. J. Nat. Prod. 1997, 60, 102-107. 35. Liang, H.; Tong, W. Y.; Zhao, Y. Y.; Cui, J. R.; Tu, G. Z. An antitumor compound julibroside J28 from Albizia julibrissin. Bioorg. Med. Chem. Lett. 2005, 15, 4493-4495. 36. Krief, S.; Thoison, O.; Sevenet, T.; Wrangham, R. W.; Lavaud, C. Triterpenoid saponin anthranilates from Albizia grandibracteata leaves ingested by primates in Uganda. J. Nat. Prod. 2005, 68, 897-903. 37. Wang, P.; Wang, J.; Guo, T. T.; Li, Y. Synthesis and cytotoxic activity of the N-acetylglucosamine-bearing triterpenoid saponins. Carbohydrate Research. 2010, 345, 607-620. 38. Yu, B.; Zhang, Y.; Tang, P. Carbohydrate chemistry in the total synthesis of saponins. Eur. J. Org. Chem. 2007, 31, 5145-5161. 39. Stallforth, P.; Lepenies, B.; Adibekian, A.; Seeberger, P. H. Carbohydrates: a frontier in medicinal chemistry. J. Med. Chem. 2009, 52, 5561-5576. 40. Nishimura, S. I.; Nomura, S.; Yamada, K. Amphiphilic poly(sugar amino acid)s: a novel class of glycoclusters for supramolecular materials. Chem. Commun. 1998, 617-618. 41. Wang, P.; Kim, Y.-J.; Navarro-Villalobos, M.; Rohde, B. D.; Gin, D. Y. Synthesis of the potent immunostimulatory adjuvant QS-21A. J. Am. Chem. Soc. 2005, 127, 3256-3257. 42. Kim, Y. J.; Wang, P.; Navarro-Villalobos, M.; Rohde, B.; Derryberry, J.; Gin, D. Y. Synthetic studies of complex immunostimulants from Quillaja saponaria: synthesis of the potent clinical immunoadjuvant QS-21Aapi. J. Am. Chem. Soc. 2006, 128, 11906-11915. 43. Codee, J. D. C.; Litjens, R. E. J. N.; den Heeten, R.; Overkleeft, H. S.; van Boom, J. H.; van der Marel, G. A. Ph2SO/Tf2O: a powerful promotor system in chemoselective glycosylations using thioglycosides. Org. Lett. 2003, 5, 1519-1522. 44. Yan, M. C.; Liu, Y.; Chen, H.; Ke, Y. Xu, Q. C.; Cheng, M. S. Synthesis and antitumor activity of two natural N-acetylglucosamine-bearing triterpenoid saponins: lotoidoside D and E. Bioorg Med Chem Lett, 2006, 16, 4200-4204. 45. Zhang, Z.; Ollmann, I. R.; Ye, X. S.; Wischnat, R.; Baasov, T.; Wong, C. H. Programmable one-pot oligosaccharide synthesis. J. Am. Chem. Soc. 1999, 121, 734-753. 46. Baytas, S. N.; Linhardt, R. J. Combinatorial carbohydrate synthesis Mini-Rev. Org. Chem. 2004, 1, 27-39. 47. Wong, C. H.; Ye, X. S.; Zhang, Z. Assembly of oligosaccharide libraries with a designed building block and an efficient orthogonal protection-deprotection strategy. J. Am. Chem. Soc. 1998, 120, 7137-7138. 48. Man, S.; Gao, W.; Zhang, Y.; Huang, L.; Liu, C. Chemical study and medical application of saponins as anti-cancer agents. Fitoterapia, 2010, 81, 703-714. 49. Winterstein, A.; Stein, G. Double bond between C-12 and C-13 of oleanolic acid is inert to catalytic hydrogenation. Z. Physiol. Chem. 1931, 202, 222-231. 50. Sun, J.; Han, X.; Yu, B. Synthesis of a typical N-acetylglucosamine-containing saponin, oleanolic acid 3-yl-α-L-arabinopyranosyl-(1→2)-α-L-arabinopyranosyl -(1→6)-2-acetamido-2-deoxy-β-D-glucopyranoside. Carbohydr. Res. 2003, 338, 827-833. 51. Ellervik, U.; Magnusson, G. Glycosylation with N-Troc-protected glycosyl donors. Carbohydr. Res. 1996, 280, 251-260. 52. Lin, C. C.; Hsu, T. S.; Lu, K. C.; Huang, I T. Synthesis of β-D -glucopyranosyl(1→3)-1-thiol-β-glucosamine disaccharide derivative as building block for the synthesis of hyaluronic acid. J. Chin. Chem. Soc. 2000, 47, 921-928. 53. Yan, M. C.; Chen, Y. N.; Wu, H. T.; Lin, C. C.; Chen, C. T.; Lin, C. C. Removal of acid-labile protecting groups on carbohydrates using water-tolerant and recoverable vanadyl triflate catalyst. J. Org. Chem. 2007, 72, 299-302. 54. Geng, Y.; Zhang, L. H.; Ye, X. S. Stereoselectivity investigation on glycosylation of oxazolidinone protected 2-amino-2-deoxy-D-glucose donors based on pre-activation protocol. Tetrahedron, 2008, 64, 4949-4958. 55. Iversen, T.; Bundle, D. R. Benzyl trichloroacetimidate, a versatile reagent for acid-catalyzed benzylation of hydroxy-groups. J. Chem. Soc., Chem. Commun. 1981, 1240−1241. 56. Saito, A.; Wakao, M.; Deguchi, H.; Mawatari, A.; Sobel, M.; Suda, Y. Toward the assembly of heparin and heparan sulfate oligosaccharide libraries: efficient synthesis of uronic acid and disaccharide building blocks. Tetrahedron 2010, 66, 3951-3962. 57. Daragics, K.; Fu‥gedi, P. (2-Nitrophenyl)acetyl: a new, selectively removable hydroxyl protecting group. Org. Lett. 2010, 12, 2076-2079. 58. Li, Y.; Yang, Y.; Yu, B. An efficient glycosylation protocol with glycosyl ortho-alkynylbenzoates as donors under the catalysis of Ph3PAuOTf. Tetrahedron Lett. 2008, 49, 3604-3608. 59. Jeker, N.; Tamm, C. Synthesis of new, unnatural macrocyclic trichothecenes: 3-isoverrucarin A (( 1'-O)(3→4)abeo-verrucarin A), verrucinol, and verrucene. Helv. Chim. Acta. 1988, 71, 1895-1903. 60. Khan, A. T.; Mondal, E. A highly efficient and useful synthetic protocol for the cleavage of tert-butyldimethylsilyl (TBS) ethers using a catalytic amount of acetyl chloride in dry methanol. Synlett. 2003, 5, 694-696. 61. Zhu, X.; Pachamuthu, K.; Schmidt, R. R. Synthesis of novel S-neoglycopeptides from glycosylthiomethyl derivatives. Org. Lett. 2004, 6, 1083-1085. 62. Zhang, H.; Samadi, A. K.; Rao, K. V.; Cohen, M. S.; Timmermann, B. N. Cytotoxic oleanane-type saponins from Albizia inundata. J. Nat. Prod. 2011, 74, 477-482. 63. Abdel-Shafeek, A. K.; El-Messiry, M. M.; Shahat, A. A.; Apers, S.; Pieters, L.; Seif-El Nasr, M. M. A new acylated flavonol triglycoside from Carrichtera annua. J. Nat. Prod. 2000, 63, 845–847. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/66466 | - |
dc.description.abstract | 從天然物中分離出三萜類以及固醇類的皂素具有多元的活性,包括抗感染、溶血活性、免疫調節以及細胞毒性等等。已有文獻報導,攜帶N-乙醯葡萄醣胺之三萜類皂素(N-Acetylglucosamine bearing triterpenoid saponins , ATS),例如:lotoidoside D,這樣獨特的類型在抗腫瘤活性上有顯著的活性。為了研究ATS之結構與活性關係分析,我們利用9種不同的醣基,分別與N-乙醯葡萄醣胺的C-3′,C-4′以及C-6′位置進行醣化反應,合成27種3-O-N-乙醯葡萄醣胺之齊墩果酸的衍生物。
為了備製這樣的衍生物,我們必須找出一個簡潔的合成過程,為了避免N-乙醯葡萄醣胺不同位置之羥基在醣化時所產生的選擇性問題,我們利用位向選擇保護(orthogonal protection)策略,合成6-O-tert-butyldiphenylsilyl-3-O-levulinoyl- 4-O-(2-nitrophenylacetyl)-2-(2,2,2-trichloroethoxylcarbonylamino)-2-deoxy-D-glucopyranosyl trichloroacetimidate (112),之後醣化在benzyl oleanolate (62) 的C-3位置,獲得化合物90,然後可以使用聯胺選擇性的去除C-3′-levulinoyl基團,得到C-3′-OH之化合物,或是以3% AcCl/MeOH移除C-6′的矽基團(tert-butyldiphenylsilyl, TBDPS),獲得C-6′-OH之化合物。而後續我們將C-3′或C-6′-OH的化合物與形成trichloroacetimidate之9種苯甲醯化的醣基,在0 oC到室溫的溫度調控下加入催化量的TMSOTf,進行醣化反應,得到C-3′或C-6′醣化之中間體。在嘗試以Zn/NH4Cl除去2-nitrophenylacetyl (NPAc)基團來得到C-4′-OH之化合物時,伴隨少量Troc基團在此環境下被去除,因而使得我們得到預期產物之產率很低。然而,化合物90TBAF/HOAc的條件下,意外獲得C-4′-NPAc基團轉移到C-6′位置的化合物149,產率為95%,所以我們以化合物149與9種不同得醣基提供者進行醣化作用,來獲得醣化在C-4′位置之3-O-N-乙醯葡萄醣胺齊墩果酸衍生物。之後將這些醣化的中間產物去除所有的保護基,得到27個3-O-N-乙醯葡萄醣胺齊墩果酸之衍生物。另外,在去除保護基的過程中,我們得到了三種N-2-methoxycarbonyl-葡萄醣胺之齊墩果酸衍生物。 在生物活性方面,我們利用SRB assay來探討這類衍生物在HL-60細胞株的細胞毒性。結果發現化合物38、173以及196 在30 μM劑量下,顯現超過80%的細胞毒性。在我們初步的SAR顯示出,3-O-N-乙醯葡萄醣胺齊墩果酸之衍生物,在C-3′位置有醣基的修飾最具有活性,C-4′位置有醣基修飾則是帶有微弱的毒性,而在醣基修飾在C-6′位置,將完全失去活性。以及,在C-3′和C-4′位置修飾之醣基為D-xylose、 L-xylose 和L-arabinose 的時候,活性好於以其他醣基修飾的衍生物。而在胺基為N-2-methoxycarbonyl修飾之化合物194和196也會增加活性。 | zh_TW |
dc.description.abstract | Triterpenoid and steroidal saponins isolated from natural plants have several biological activities, including anti-infection, hemolytic activity, immune-modulation, cytotoxicity, and etc. N-Acetylglucosamine bearing triterpenoid saponins (ATS), such as lotoidoside D, were reported to be a unique type of saponins with potent anti-tumor activity. In order to study the SAR of ATS, we synthesized 27 derivatives of 3-O-N-acetylglucosaminoyl oleanolic acid, with additional 9 sugars glycosylated either at 3', 4', and 6' positions of N-acetylglucosamine.
It is highly essential to develop a concise procedure to prepare these derivatives. To circumvent the problem associated with selective glycosylate sugars at specific of hydroxyl groups of D-glucosamine, it was orthogonal protected to 6-O-tert- butyldiphenylsilyl-3-O-levulinoyl-4-O-(2-nitrophenylacetyl)-2-(2,2,2-trichloroethoxylcarbonylamino)-2-deoxy-D-glucopyranosyl trichloroacetimidate (112). Following by glycosylation with benzyl oleanolate at C-3-OH, compound 90 was obtained, which was selected deprotected by using hydrazine to free 3-hydroxyl group from levulinoyl group, or 3% AcCl/MeOH to free 6-hydroxyl group from 6-tert-butyldiphenylsilyl group. The free hydroxyl groups at 3' or 6' of glucosamine were further glycosylated with 9 per-benzoylated glycosyl trichloroacetimidates in the presence of TMSOTf at 0 oC to rt to afford 3' or 6' glycosylated intermedidates. In an attempt to free 4-hydroxyl group from 2-nitrophenylacetyl group by Zn in ammonia chloride, we suffered from low yield of desired product due to concomitant removal of Troc group in this condition. However, when compound 90 was subjected to TBAF/HOAc condition, we accidently obtained the 4', 6'-migration of 2-nitrophenylacetyl group in 95% yield to afford compound 149 which was glycosylated with 9 sugar donors to get the desired 4'-glycosylated products. The global deprotection of glycosylated intermediates afforded 27 3-O-N-acetylglucosaminoyl oleanolic acid derivatives. Three N-2-methoxycarbonyl D-glucosaminoyl oleanolic acid derivatives were also obtained as side products in the global deprotecting process. The effect of these derivatives on HL-60 cell line was studied via SRB assay. Compounds 38, 173, and 196 showed more than 80% of cytotoxicity at 30 miuM. The preliminary SAR results indicated that the modification at 3’ position retained most of cytotoxicity of 3-O-N-acetylglucosaminoyl oleanolic acid, modification at 4’ position have moderate cytotoxicity, and modification at 6' position completely loss the activity. D-Xylose, L-xylose and L-arabinose attached at 3' or 4' positions were found to be active among these modifications. Compounds 194 and 196 with N-2-methoxycarbonyl modification at 2'-amino position was found to increase the cytotoxicity. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T00:37:13Z (GMT). No. of bitstreams: 1 ntu-100-R98423022-1.pdf: 10010834 bytes, checksum: c48e7eedcc60445096f05c25a770c5fd (MD5) Previous issue date: 2011 | en |
dc.description.tableofcontents | 目錄 Ⅰ
圖目錄 Ⅲ 路徑目錄 Ⅳ 表目錄 Ⅴ 詞彙 Ⅵ 中文摘要 Ⅸ 英文摘要 XI 一、研究背景 1 1.1. 皂素(saponin)之簡介 1 1.2. 齊墩果酸(oleanolic acid) 2 1.3. 齊墩果酸及其類似物之結構分析 3 1.4. 齊墩果酸配醣體之合成方法 11 1.4.1. 醣化作用之逆合成分析 11 1.4.1.1.聚合型合成方法 13 1.4.1.2.直線型合成方法 15 1.4.2. 醣基部分的合成方法 17 1.4.2.1.一鍋化(one-pot)的合成策略 17 1.4.2.2.隨機醣化(random glycosylation)的合成策略18 1.4.2.3.Orthogonal protection的合成策略 18 1.5.研究動機與目的 20 二、結果與討論 22 2.1. 合成策略與方法 22 2.1.1. 齊墩果酸配醣體之逆合成分析 22 2.1.2. Benzyl oleanolate的備製 23 2.1.3. D-Glucosamine保護基合成策略 24 2.1.4. 延伸之醣基作為供給者之合成路徑 30 2.1.5. 核心結構及類似物的合成 32 2.1.6. 確定化合物結構之方法 43 2.2.生物活性 50 三、結論 53 四、實驗部分 54 4.1.實驗試劑及儀器來源 54 4.2.合成步驟及數據 57 五、參考文獻 174 六、附圖 182 | |
dc.language.iso | zh-TW | |
dc.title | 合成含N-乙醯葡萄糖胺之齊墩果酸醣類分子庫及其抗癌之研究 | zh_TW |
dc.title | Synthesis Glycosyl Library of N-Acetylglucosamine-Bearing Oleanolic acid and their Anticancer Activity | en |
dc.type | Thesis | |
dc.date.schoolyear | 100-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 李水盛,忻凌偉,顧記華 | |
dc.subject.keyword | N-乙醯葡萄糖胺,齊墩果酸,抗癌, | zh_TW |
dc.subject.keyword | N-Acetylglucosamine,Oleanolic acid,Anticancer Activity, | en |
dc.relation.page | 320 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2012-02-02 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 藥學研究所 | zh_TW |
顯示於系所單位: | 藥學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-100-1.pdf 目前未授權公開取用 | 9.78 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。